Jacqualyn A. Fouse

Strategic Advisor to the Executive Committee of Celgene Corporation
Director since 2010

Dr. Fouse has served on the Board since 2010. Dr. Fouse currently serves as a Strategic Advisor to the Executive Committee of Celgene Corporation, a global biopharmaceutical company listed on Nasdaq, a position to which she was appointed April 2017. Dr. Fouse served as the President and Chief Operating Officer of Celgene Corporation from March 2016 to April 2017, as the President, Global Hematology and Oncology from August 2014 to March 2016, and as the as the Chief Financial Officer from September 2010 to August 2014. She formerly served as Chief Financial Officer of Bunge Limited, a global agribusiness and food company listed on the NYSE, from 2007 to 2010. From 2006 to 2007, Dr. Fouse was the Senior Vice President, Chief Financial Officer and Corporate Strategy Officer at Alcon, Inc., a global eye care company listed on the NYSE, and from 2002 she was Alcon’s Senior Vice President and Chief Financial Officer. Dr. Fouse served as the Chief Financial Officer of Swiss Air Group in Switzerland from 2001 to 2002. Previously, Dr. Fouse held a variety of senior finance positions at Alcon and its then majority owner Nestlé SA. Dr. Fouse was elected to the board of directors of Celgene Corporation in February 2016 but will not stand for re-election to the board in 2017, and Dr. Fouse served on the board of directors of Perrigo Company from November 2012 to April 2016. She also serves on the advisory boards at the University of Texas at Arlington and Texas Christian University.